| UNCY Stock | | | USD 0.62 0.01 1.64% |
Unicycive Therapeutics Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio will likely drop to 16.04 in 2025.
Check out the analysis of
Unicycive Therapeutics Correlation against competitors.
For more information on how to buy Unicycive Stock please use our
How to Invest in Unicycive Therapeutics guide.
Latest Unicycive Therapeutics' Price To Sales Growth Pattern
Below is the plot of the Price To Sales Ratio of Unicycive Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Unicycive Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Unicycive Therapeutics sales, a figure that is much harder to manipulate than other Unicycive Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Unicycive Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Unicycive Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 62.82 X | 10 Years Trend | | |
Unicycive Price To Sales Regression Statistics
| Arithmetic Mean | 11.70 |
| Geometric Mean | 10.40 |
| Coefficient Of Variation | 63.23 |
| Mean Deviation | 5.11 |
| Median | 8.55 |
| Standard Deviation | 7.39 |
| Sample Variance | 54.68 |
| Range | 22.9951 |
| R-Value | 0.59 |
| Mean Square Error | 38.19 |
| R-Squared | 0.35 |
| Significance | 0.02 |
| Slope | 0.92 |
| Total Sum of Squares | 820.22 |
Unicycive Price To Sales History
| 2025 | 16.04 | |
| 2024 | 28.39 | |
| 2023 | 31.54 | |
About Unicycive Therapeutics Financial Statements
Unicycive Therapeutics investors use historical fundamental indicators, such as Unicycive Therapeutics' Price To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Unicycive Therapeutics. Please read more on our
technical analysis and
fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Unicycive Stock Analysis
When running Unicycive Therapeutics' price analysis, check to
measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.